Sinn, Bruno Valentin <br/><br/>
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.  [electronic resource] 

 -  Breast cancer research : BCR  12 2019 
 - 142 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/s13058-019-1231-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biomarkers, Tumor<br/>Breast Neoplasms--drug therapy<br/>Female<br/>Gene Expression<br/>Histocompatibility Antigens Class I--genetics<br/>Humans<br/>Immunohistochemistry<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptor, ErbB-2--deficiency<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Treatment Outcome<br/>Tumor Microenvironment